Neoantigens released after tumor cell death initiate a number of processes that ultimately lead to T cells that recognize cancer cells through the interaction of distinct T-cell receptors (TCR) with specific neoantigen–MHC complexes. This evidence concerns the gene HLA-C and neoplasm.